Whats the latest information about MPN treatment and research? As part of our ASH 2017 coverage, Dr. John Crispino and Dr. Angela Fleischman, Joined Patient Power to share what they learned at this years annual meeting in Atlanta. Both researchers in the condition of myeloproliferative neoplasms (MPNs), they discussed treatment advances, particularly related to JAK inhibitors and interferon, the study of somatic mutations and how these learnings will aid in the development of future medicines. Tune in now to learn more from these MPN experts.
What the MPN Experts Learned at ASH 2017
